Featured Product
This Week in Quality Digest Live
FDA Compliance Features
Etienne Nichols
What’s the difference?
Liza Dzhezhora
How to ensure the integration of IoMT devices in your practice
Del Williams
Options to address the risk of combustible dust explosions for NFPA 61 compliance
Doug Folsom
Unpatched vulnerabilities will become increasingly susceptible to cyberattacks
Del Williams
Mitigate risk, prevent safety issues by utilizing closed conveyor systems designed with sanitation in mind

More Features

FDA Compliance News
Creates one of the most comprehensive regulatory SaaS platforms for the industry
Company’s first funding round will be used to accelerate product development for its QMS and MES SaaS offerings
Showcasing tech, solutions, and services at Gulfood Manufacturing 2022
Easy, reliable leak testing with methylene blue
Now is not the time to skip critical factory audits and supply chain assessments
Google Docs collaboration, more efficient management of quality deviations
Delivers time, cost, and efficiency savings while streamlining compliance activity
First trial module of learning tool focuses on ISO 9001 and is available now
Free education source for global medical device community

More News

Quality Digest

FDA Compliance

Chemir Pharma Services Changes Name to Azopharma

Published: Tuesday, June 21, 2005 - 22:00

Chemir Pharma Services recently changed its name to Azopharma in response to its extensive growth and commitment as a contract pharmaceutical services provider.  Azopharma is a FDA-registered and cGMP-compliant research and development organization that supports the development and commercialization of pharmaceutical, biotech and medical devices.

The company’s Phase 1 Express project allows pharmaceutical companies to form clinical trials and includes preformulation, formulation, analytical R&D, QC release, stability, manufacturing, packaging and labeling of clinical supplies for Phase 1 development.

“Timing is a critical factor on the road to successful clinical study,” says Phil Meeks, Azopharma CEO. “We can now assist our customers in all phases of drug development for Phase 1 clinical supplies. Our Phase 1 Express will raise the bar in the industry and bring unsurpassed speed to the development of clinical materials.”

For more information, visit www.azopharma.com.


About The Author

Quality Digest’s picture

Quality Digest

For 40 years Quality Digest has been the go-to source for all things quality. Our newsletter, Quality Digest, shares expert commentary and relevant industry resources to assist our readers in their quest for continuous improvement. Our website includes every column and article from the newsletter since May 2009 as well as back issues of Quality Digest magazine to August 1995. We are committed to promoting a view wherein quality is not a niche, but an integral part of every phase of manufacturing and services.